However, it remains to be eludicated whether these associations are causal (e.g., via mTOR activation) or consequential (e.g., due to reduced mitochondrial oxidation) in metabolic disease, (Lynch and Adams, 2014) and whether UPF intake plays a role in the etiology of the association of BCAAs with metabolic health. This evidence concerns the gene MTOR and metabolic disease.